Specifically, fucoidan treatment significantly upregulated the expression of Zo-1 and occludin proteins in the colon, which were notably reduced in PD mice, thereby restoring intestinal barrier integrity and ameliorating gut dysfunction. Here, OCLN is linked to Parkinson disease.